To Explore the Influence of Appetite Reduction and Medication Effect of Methylphenidate in Patients With Attention-deficit/Hyperactivity Disorder(ADHD) Through Pharmacogenetics.
CompletedOBSERVATIONAL
Enrollment
110
Participants
Timeline
Start Date
July 1, 2019
Primary Completion Date
February 1, 2022
Study Completion Date
February 1, 2022
Conditions
Methylphenidate Adverse Reaction
Trial Locations (1)
333
Linkou Chang Gung Memorial Hospital, Taoyuan District
All Listed Sponsors
lead
Chang Gung Memorial Hospital
OTHER
NCT04006548 - To Explore the Influence of Appetite Reduction and Medication Effect of Methylphenidate in Patients With Attention-deficit/Hyperactivity Disorder(ADHD) Through Pharmacogenetics. | Biotech Hunter | Biotech Hunter